JP2018526330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018526330A5 JP2018526330A5 JP2017567174A JP2017567174A JP2018526330A5 JP 2018526330 A5 JP2018526330 A5 JP 2018526330A5 JP 2017567174 A JP2017567174 A JP 2017567174A JP 2017567174 A JP2017567174 A JP 2017567174A JP 2018526330 A5 JP2018526330 A5 JP 2018526330A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- cdr
- antibody
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562185362P | 2015-06-26 | 2015-06-26 | |
| US62/185,362 | 2015-06-26 | ||
| PCT/US2016/039087 WO2016210172A1 (en) | 2015-06-26 | 2016-06-23 | Methods of treating autoimmune and alloimmune disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018526330A JP2018526330A (ja) | 2018-09-13 |
| JP2018526330A5 true JP2018526330A5 (cg-RX-API-DMAC10.html) | 2019-07-25 |
| JP6963509B2 JP6963509B2 (ja) | 2021-11-10 |
Family
ID=57585852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017567174A Active JP6963509B2 (ja) | 2015-06-26 | 2016-06-23 | 自己免疫障害及び同種免疫障害の処置方法 |
Country Status (12)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014066744A2 (en) | 2012-10-25 | 2014-05-01 | True North Therapeutics, Inc. | Anti-complement c1s antibodies and uses thereof |
| ES2912396T3 (es) | 2012-11-02 | 2022-05-25 | Bioverativ Usa Inc | Anticuerpos anti-C1s del complemento y uso de los mismos |
| EP4212175A1 (en) | 2015-04-06 | 2023-07-19 | Bioverativ USA Inc. | Humanized anti-c1s antibodies and methods of use thereof |
| KR102527840B1 (ko) | 2016-04-29 | 2023-05-03 | 화이자 인코포레이티드 | 인터페론 베타 항체 및 그의 용도 |
| IL326479A (en) | 2016-10-12 | 2026-04-01 | Bioverativ Usa Inc | Anti-c1s antibodies and methods of use thereof |
| EP4640703A3 (en) | 2017-11-14 | 2026-04-08 | Chugai Seiyaku Kabushiki Kaisha | Anti-c1s antibodies and methods of use |
| CA3137649A1 (en) | 2019-05-15 | 2020-11-19 | Chugai Seiyaku Kabushiki Kaisha | An antigen-binding molecule, a pharmaceutical composition, and a method |
| BR112022006014A2 (pt) * | 2019-10-16 | 2022-07-12 | Chugai Pharmaceutical Co Ltd | Anticorpo, composição farmacêutica e método |
| BR112023001942A2 (pt) * | 2020-08-06 | 2023-02-28 | Bioverativ Usa Inc | Citocinas inflamatórias e fadiga em indivíduo com doença mediada por complemento |
| CN117642431B (zh) | 2021-07-13 | 2025-07-15 | 迈威(美国)生物治疗有限公司 | 抗c1s抗体和其用途 |
| MA71249A (fr) | 2022-06-24 | 2025-04-30 | Bioverativ Usa Inc. | Méthodes de traitement de maladies médiées par complément |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001013945A1 (en) * | 1999-08-23 | 2001-03-01 | Biocrystal Ltd. | Methods and compositions for immunotherapy of b cell involvement in promotion of a disease condition comprising multiple sclerosis |
| EP1545611B1 (en) * | 2002-09-06 | 2016-11-09 | Alexion Pharmaceuticals, Inc. | Method of treatment of asthma using antibodies to complement component c5 |
| US7361339B2 (en) * | 2003-01-09 | 2008-04-22 | Alexion Pharmaceuticals, Inc. | Methods for reducing morality associated with acute myocardial infarction |
| CA2720682A1 (en) * | 2008-04-25 | 2009-10-29 | Zymogenetics, Inc. | Levels of bcma protein expression on b cells and use in diagnostic methods |
| NZ597259A (en) * | 2009-06-23 | 2014-04-30 | Alexion Pharma Inc | Bispecific antibodies that bind to complement proteins |
| WO2014066744A2 (en) * | 2012-10-25 | 2014-05-01 | True North Therapeutics, Inc. | Anti-complement c1s antibodies and uses thereof |
| ES2912396T3 (es) * | 2012-11-02 | 2022-05-25 | Bioverativ Usa Inc | Anticuerpos anti-C1s del complemento y uso de los mismos |
-
2016
- 2016-06-23 HK HK18112887.1A patent/HK1254030A1/zh unknown
- 2016-06-23 MX MX2017016835A patent/MX2017016835A/es unknown
- 2016-06-23 IL IL256424A patent/IL256424B2/en unknown
- 2016-06-23 WO PCT/US2016/039087 patent/WO2016210172A1/en not_active Ceased
- 2016-06-23 CA CA2990662A patent/CA2990662A1/en active Pending
- 2016-06-23 EA EA201890106A patent/EA038567B1/ru unknown
- 2016-06-23 KR KR1020187002518A patent/KR20180020296A/ko active Pending
- 2016-06-23 AU AU2016282782A patent/AU2016282782A1/en not_active Abandoned
- 2016-06-23 US US15/739,622 patent/US20180169240A1/en not_active Abandoned
- 2016-06-23 EP EP16815332.8A patent/EP3313417A4/en not_active Withdrawn
- 2016-06-23 JP JP2017567174A patent/JP6963509B2/ja active Active
- 2016-06-23 CN CN201680044603.9A patent/CN108348600A/zh active Pending
-
2017
- 2017-12-19 MX MX2023002021A patent/MX2023002021A/es unknown
-
2021
- 2021-09-08 US US17/469,625 patent/US20220249664A1/en not_active Abandoned
-
2022
- 2022-08-12 AU AU2022215307A patent/AU2022215307B2/en not_active Expired - Fee Related
-
2024
- 2024-12-03 US US18/966,631 patent/US20250295768A1/en active Pending